Roanoke-based cancer research startup, Acomhal Research Inc., secured a $399,878 Small Business Technology Transfer grant to determine if a molecule that stalls the spread of invasive brain cancer stem cells can help treat aggressive forms of breast cancer.
A dose of adenovirus hits most people like a common cold – a cough, a fever, maybe a sore throat. But for an unfortunate few, the usually benign bug hacks the heart’s cellular electrical communication system and sometimes proves fatal.
Good things come in small packages. Launched by Fralin Biomedical Research Institute’s Robert Gourdie, The Tiny Cargo Co. will package vital heart medicine in nano-containers extracted from cow’s milk.
With a focus on health sciences and technology, the HS&T Hokie Pitch will involve 30 students who have worked with real-world mentors, selected intellectual property, and created an entrepreneurial plan to develop and commercialize biomedical discoveries.
Laura Beth Payne, a postdoctoral associate at the Fralin Biomedical Research Institute at VTC, has been awarded a two-year American Heart Association postdoctoral fellowship to study molecular interactions in healthy and abnormal microvasculature.
The three-year American Heart Association Transformational Project Award will help heart and reparative medicine researchers at the Fralin Biomedical Research Institute at VTC examine the complex effects of ischemic brain injuries on blood vessels.
For the second year, Roanoke youth enrolled in Goodwill Industries of the Valley's YouthHQ@Goodwill Science Camp visited the Fralin Biomedical Research Institute at VTC this week. The campers learned about careers in science, microscopy, genetics, viruses, and how a heartbeat happens.
Researchers at the Fralin Biomedical Research Institute at VTC have revealed how a genetic message to produce healthy heart tissue is altered in the body during stress and aging to contribute to sudden cardiac death.
To explore potential sources of cellular electrical communication, the Fralin Biomedical Research Institute at VTC is hosting the world’s first Ephaptic Coupling Conference in Roanoke, Virginia, from May 5 to 7.
Teams will compete for $9,000 in prize money provided by the Virginia Tech Carilion Research Institute, Luna Innovations Inc., Carilion Clinic, the Apex Systems Center for Innovation and Entrepreneurship, and the Woods Rogers law firm.
Scientists at the Virginia Tech Carilion Research Institute have found evidence that may disrupt conventional understanding about how electrical activity travels in the heart — a discovery that potentially can lead to new insight into medical problems, such as heart arrhythmia and sudden cardiac death.
Deb Kelly, who is also an associate professor of biological sciences in the College of Science at Virginia Tech, is working to better detect, prevent, and repair the mutations found in cancers related to the breast cancer susceptibility protein, BRCA1.
The research team was led by Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, and Soufian AlMahameed, who was a clinician associate professor at the Virginia Tech Carilion School of Medicine and the director of Carilion Clinic’s Center for Atrial Fibrillation at the time of data collection.
Scientists at the Virginia Tech Carilion Research Institute have added a new dimension to the understanding of how cells alter their communication with one another during development, wound healing, and the spread of cancer.
Von Hippel-Lindau syndrome is a rare disease, affecting about one in every 36,000 people, according to the National Institutes of Health. People with the disorder have an increased risk for developing cancer, but a main concern is on the syndrome’s characteristic benign growths.